Browsing: Medication & Drugs

The Food and Drug Administration (FDA) has issued a public health warning concerning purchasing and using 17 unregistered drug products.

Log In or Register as a healthcare professional to read the full article.

Sumatran orangutan treats wounds with medicinal plants, raising questions about animal intelligence and the potential for collaboration in traditional medicine.

Antibiotic misuse is a significant threat. According to the World Health Organization (WHO), antibiotic resistance is one of the top global public health threats, estimated to cause millions of deaths annually.

Why Finishing Your Antibiotics Could Save Lives Imagine a world where common infections are once again deadly. This could be…

In the healthcare landscape, the choice between house brand and branded medications often hinges on cost and consumer confidence. Interestingly, scientific evidence counters this by highlighting that the active ingredients in generic (house brand) and brand-name drugs are identical, ensuring comparable efficacy.

The Versatile Powerhouse: Coconut Oil’s Global Impact Coconut oil, a cornerstone of Southeast Asian culture, has been woven into the…

In crafting legislation, Marcos emphasises the need to prioritise equity and social responsibility, particularly concerning access to medical marijuana among marginalised communities. By addressing disparities in healthcare access and fostering inclusivity, policymakers can ensure that the benefits of medical marijuana are accessible to all who stand to benefit.

In conclusion, Senator Imee Marcos’s advocacy for strengthening the bill seeking to legalise medical marijuana reflects a commitment to ensuring the responsible and effective implementation of cannabis-based therapies. As legislative efforts evolve, the imperative remains to balance compassion for needy patients and safeguarding public health and safety. Policymakers can pave the way for a more compassionate and practical approach to medical marijuana regulation.

The Food and Drug Administration (FDA) has revealed plans to establish a task force to target online sellers engaged in distributing fake products and deceptive advertising. 

This is executed in a significant move to fortify consumer protection and combat the rising tide of counterfeit goods. This initiative is particularly pertinent given the growing concerns surrounding dubious skincare and supplement products, predominantly marketed through social media platforms.

In a recent announcement, the Food and Drug Administration (FDA) has urged healthcare professionals to promptly report any adverse reactions linked to the use of anaesthesia. This directive comes in response to mounting concerns raised by healthcare practitioners regarding the efficacy of certain anaesthesia products. Particularly, those containing bupivacaine, a potent local anaesthetic, have drawn significant attention. The FDA’s stance aims to address these concerns and ensure patient safety in anaesthesia administration.